What’s Trending?

Aspen Pharmacare, pursuing J&J vaccine license, aims to shore up local capacity and quash shot inequality in Africa fkansteiner Thu, 12/02/2021 - 07:59 [...]
Thu, Dec 02, 2021
Source FiercePharma
Researchers have identified in those patients experiencing blood clots after vaccination a subsequent condition referred to as vaccine-induced immune thrombotic thrombocytopenia (VITT). [...]
Thu, Dec 02, 2021
Source PharmaTimes
Scientists and health experts have cautioned that the new variant could have the ability to bypass the effectiveness of vaccines that are currently available. [...]
Thu, Dec 02, 2021
Source PharmaTimes
Fujifilm socks $530M into U.K. vaccine, gene therapy and microbial production, creating 350 jobs fkansteiner Wed, 12/01/2021 - 16:45 [...]
Wed, Dec 01, 2021
Source FiercePharma
Sanofi aims to double vaccine sales by 2030, citing RSV and flu market expansion as key drivers esagonowsky Wed, 12/01/2021 - 13:51 [...]
Wed, Dec 01, 2021
Source FiercePharma
Moderna loses bid to invalidate vaccine delivery patents, teeing up potential infringement lawsuit fkansteiner Wed, 12/01/2021 - 12:42 [...]
Wed, Dec 01, 2021
Source FiercePharma
Amid the COVID-19 pandemic, the NHS faces staff and hospital equipment shortages alongside the growing need to reduce the backlog in patient surgeries and treatments. [...]
Wed, Dec 01, 2021
Source PharmaTimes
The UK government has aimed to expand their COVID-19 vaccination programme, in accordance with guidance from the Joint Committee on Vaccination and Immunisation (JCVI). [...]
Wed, Dec 01, 2021
Source PharmaTimes
The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force (CITF). [...]
Wed, Dec 01, 2021
Source WorldPharmaNews
GlaxoSmithKline
GlaxoSmithKline (GSK) plc today launched Target the Future, an international, multi-year initiative dedicated to advancing innovation and addressing key needs in the multiple myeloma community. The programme will provide education on progress in the field of multiple myeloma, identify key challenges the community faces, and facilitate solutions to help create [...]
Wed, Dec 01, 2021
Source WorldPharmaNews
From May 23 to August 13, 2021, the Institut Pasteur, in partnership with the French National Health Insurance Fund (CNAM), Santé publique France and the Ipsos institute, conducted the fourth part of the ComCor epidemiological study on circumstances and places of infection with the SARS-CoV-2 virus in France. The aim [...]
Tue, Nov 30, 2021
Source WorldPharmaNews
WHO
On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO's Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an impact on [...]
Mon, Nov 29, 2021
Source WorldPharmaNews
Sponsors submitting pediatric study plans should consider whether a product affects adults and children similarly when choosing an approach, the FDA says. [...]
Fri, Jan 16, 2015
Source FDANews